PD1 TurboCAR™ T Cells: PD1-Resistant CAR T Cells With Programmable Cytokine Signaling Outputs
American Association for Cancer Research (AACR) June 2020 – SMIC CAR T Cells: CAR T with Temporally-Controlled, Programmable Cytokine Signaling Outputs
American Society of Gene and Cell Therapy (ASGCT) May 2020 - TurboCAR™ T Cells: CAR T Cells with Constitutive, Programmable Cytokine Signaling Outputs
Toward “Off-the-Shelf” Allogeneic CAR T Cells
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies Valton J, Guyot V, Boldajipour B, et al.
American Society of Gene and Cell Therapy (ASGCT) May 2018 – Development of an In Vitro Cynomolgus Macaque Allogeneic CAR T Cell Platform